Skip to main content

Table 4 Financial performance simulation results

From: A decision support tool with health economic modelling for better management of DVT patients

Scenario

Cost of standard care (incl. drug costs, FU’s and first visits)

Cost of NOAC (incl. drug costs, FU’s and first visits)

Staff cost

Total cost

Baseline

ÂŁ2,811,048

ÂŁ0

ÂŁ1,774,893

ÂŁ4,585,941

Scenario 1

ÂŁ2,398,573

ÂŁ116,898

ÂŁ1,613,095

ÂŁ4,128,567

Scenario 2

ÂŁ2,054,464

ÂŁ224,410

ÂŁ1,415,775

ÂŁ3,694,649

Scenario 3

ÂŁ1,553,305

ÂŁ403,630

ÂŁ1,114,937

ÂŁ3,071,872

Scenario 4

ÂŁ1,262,138

ÂŁ505,103

ÂŁ960,037

ÂŁ2,727,278

Scenario 5

ÂŁ2,212,853

ÂŁ125,184

ÂŁ1,585,241

ÂŁ3,923,278

Scenario 6

ÂŁ1,898,084

ÂŁ217,774

ÂŁ1,399,161

ÂŁ3,515,018

Scenario 7

ÂŁ1,452,477

ÂŁ387,149

ÂŁ1,124,391

ÂŁ2,964,016

Scenario 8

ÂŁ1,175,053

ÂŁ483,188

ÂŁ956,465

ÂŁ2,614,699

Scenario 9

ÂŁ1,831,531

ÂŁ143,566

ÂŁ1,509,454

ÂŁ3,484,551

Scenario 10

ÂŁ1,580,015

ÂŁ227,182

ÂŁ1,345,870

ÂŁ3,153,067

Scenario 11

ÂŁ1,242,852

ÂŁ359,149

ÂŁ1,128,102

ÂŁ2,730,103

Scenario 12

ÂŁ1,018,522

ÂŁ438,128

ÂŁ971,924

ÂŁ2,428,574

Scenario 13

ÂŁ1,666,528

ÂŁ153,471

ÂŁ1,490,022

ÂŁ3,310,021

Scenario 14

ÂŁ1,428,968

ÂŁ231,599

ÂŁ1,317,754

ÂŁ2,978,321

Scenario 15

ÂŁ1,128,107

ÂŁ352,167

ÂŁ1,114,044

ÂŁ2,594,319

Scenario 16

ÂŁ915,767

ÂŁ425,174

ÂŁ954,032

ÂŁ2,294,973

  1. NOAC Novel Oral Anticoagulant treatment, FU Follow-up